Dr. Scott Jewell is a nationally recognized expert in biobanking, which encompasses the management and storage of the crucial biological samples that facilitate research into health and disease.

He earned a B.S. in microbiology and an M.S. and Ph.D. in experimental pathology and immunology from The Ohio State University. For the past four decades, he has worked in and contributed to best practices for clinical and anatomic pathology, biospecimen science and biobanking. He served as director of OSU’s Human Tissue Resource Network and as associate director of the OSU Comprehensive Cancer Center’s Biorepository and Biospecimen Resource, where his dedicated, creative efforts led to the development of a state-of-the-art tissue procurement and biorepository system. He joined Van Andel Institute in 2010, where he led the growth of Institute’s state-of-the-art, accredited Pathology and Biorepository Core. From 2010–2022, he also served as director of VAI’s Core Technologies and Services, which offer leading-edge technologies and expertise to scientists at the Institute and beyond. As director of the Pathology and Biorepository Core, Dr. Jewell leads the Core’s participation in several national, collaborative projects, including the Cancer Moonshot^SM, the National Institutes of Health’s Biospecimen Pre-Analytical Variables Program and NIH’s Clinical Proteomic Tumor Analysis Consortium. VAI’s Biorepository also serves as the biobank for several research efforts and consortia, including the Van Andel Institute–Stand Up To Cancer Epigenetics Dream Team, CombinedBrain, Rare-X Disease, VAI’s MiND Program, and VAI’s MeNu Program. He also led the Core’s contributions to NIH’s Genome Tissue Expression (GTEx) project and the Multiple Myeloma Research Foundation’s CoMMPass study, among others.

He was elected President of the International Society for Biological and Environmental Repositories (ISBER) from 2009–2010. He also is a past member of the College of American Pathologist’s (CAP) Biorepository Accreditation Program (2010–2018) and presently is on the editorial board of the journal Biopreservation and Biobanking and several cancer centers’ external advisory boards for biospecimen resources.